JAMA Network

09/21/2023

Listen to Dr Michael Howell and Dr Kirsten Bibbins-Domingo discuss concepts in AI including gaslighting, reinforcement learning & hallucinations in first episode of new “AI and Clinical Practice” series.

🔊: https://ja.ma/3ZnvROw

Also on Apple Podcasts and Spotify: JAMA Medical News

09/27/2022

Viewpoint discusses fi****ms, su***de, and approaches for prevention, including lethal means safety, in which access to fi****ms and other lethal methods is reduced—an evidence-based approach to reducing su***de risk. https://ja.ma/3ShGPR3

This Viewpoint discusses lethal means safety (LMS), an approach to reducing su***de risk by reducing access to fi****ms by at-risk individuals; highlights challenges in implementing LMS interventions in clinical settings; and provides examples of programs and resources for preventing firearm su***de...

07/17/2022

Kirsten Bibbins-Domingo, PhD, MD, MAS, is the 17th editor in chief of JAMA and the JAMA Network. Learn more about her and vision for the 13 journals in her inaugural editorial. https://ja.ma/3PwP8qI

07/17/2022

Kirsten Bibbins-Domingo, PhD, MD, MAS, is the 17th editor in chief of JAMA and the JAMA Network. Learn more about her and vision for the 13 journals in her inaugural editorial. https://ja.ma/3PddXYG

07/16/2022

Kirsten Bibbins-Domingo, PhD, MD, MAS, is the 17th editor in chief of JAMA and the JAMA Network. Learn more about her and vision for the 13 journals in her inaugural editorial. https://ja.ma/3yAOkKs

07/12/2022

Kirsten Bibbins-Domingo, PhD, MD, MAS, is the 17th editor in chief of JAMA and the JAMA Network. Learn more about her and vision for the 13 journals in her inaugural editorial. https://ja.ma/3NWhKrY

07/11/2022

07/05/2022

Welcome Kirsten Bibbins-Domingo, PhD, MD, MAS, as the 17th editor in chief of JAMA and the JAMA Network. Learn more about her and her vision for the 13 journals in her inaugural editorial. https://ja.ma/3P3Hi7I

04/11/2022

The AMA announced the hiring of Kirsten Bibbins-Domingo, M.D., Ph.D., M.A.S., as the next editor-in-chief of JAMA and JAMA Network™.

12/28/2021

12/06/2021

11/16/2021

Five drugs are now approved by the US FDA for long term weight management in adults: - Orlistat- Phentermine/topiramate- Naltrexone/bupropion XR- Liraglutide...

03/15/2021

03/04/2021

02/26/2021

02/17/2021

02/08/2021

02/04/2021

01/19/2021

01/11/2021

01/05/2021

12/25/2020

In this narrative medicine essay, a family practitioner tells the story of how her relationship with an old order Mennonite woman whose newborn son she examined and took to the hospital for cardiac surgery one Christmas day turns to friendship and a relationship with her broader community when the.....

12/02/2020

11/16/2020

11/15/2020

This randomized trial examines the effects on cardiovascular outcomes of a carboxylic acid formulation of EPA and DHA (omega-3 CA) with documented favorable effects on lipid and inflammatory markers in patients with atherogenic dyslipidemia and high cardiovascular risk.